Astia — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Zenflow develops medical devices for treating benign prostatic hyperplasia (BPH) in men, founded from the Stanford Byers Center for Biodesign with a team experienced in medical device development and FDA regulation.
HealthtechMedical DevicesSan Francisco, US
Shreya Mehta(Founder/CTO)inNick Damiano(Executive Officer, Director)John Beck(Executive Officer)
BoardBryan Kim(Director)Robert Weisskoff(Director)inBlayne Roeder(Director)
Co-investorsShangBay Capital LLCY CombinatorDorm RoomF-Prime CapitalF-Prime Capital PartnersGolden Seeds+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.